头孢噻肟钠-阿莫西林克拉维酸钾转换疗法治疗小儿支气管肺炎的临床观察  

Observation on the Switch Therapy of Cefotaxime-Amoxicillin and Clavulanate Potassium in Treatment of children with Bronchopneumonia

作　　者：李云兴[1] 

机构地区：[1]深圳市宝安区西乡人民医院儿科,广东深圳518102

出　　处：《实用临床医学（江西）》2005年第5期117-119,共3页Practical Clinical Medicine

摘　　要：目的:观察头孢噻肟钠-阿莫西林克拉维酸钾转换疗法治疗小儿支气管肺炎的疗效.方法:将60例支气管肺炎患儿随机分为两组,观察组30例,予头孢噻肟钠-阿莫西林克拉维酸钾转换疗法治疗;对照组30例,持续给予头孢噻肟钠静脉滴住,每日1次,两组疗程均为7～10 d,并给予常规对症、支持治疗,观察治疗效果,比较两组的住院天数和治疗费用.结果:与对照组比较,两组治疗效果无显著差异(P＞0.05),但观察组住院天数短,总治疗费用低,与对照组比较,差异显著(P＜0.05).结论:头孢噻肟钠-阿莫西林克拉维酸钾转换疗法治疗小儿支气管肺炎疗效肯定,具有可行性、安全性、实用性、经济性.Objective:To observe the therapeutic effect of Cefotaxime-Amoxicillin and Clavulanate Potassium in treatment of children with bronchopneumonia.Methods:Sixty cases were divided into two groups at random,besides the routine treatment, the patients in observation group(30 cases)was treated with Cefotaxime-Amoxicillin and Clavulanate Potassium by switch therapy and the control group(30cases)was treated with cefotaxime in the form of intravenous, taking 7~10 days as a course.Results:The efficacy of treatment had not significant difference between two groups(P>0.05),while compared with the control group,the hospitalization course were shortened and the total cost for treatment was reduced in the observation group with a significant difference(P<0.05).Conclusion:To treat bronchopneumonia in children with Cefotaxime-Amoxicillin and Clavulanate Potassium by switch therapy may get a certain effect and it can save medical resources,thus the therapy should be improved in clinics.

关 键 词：支气管肺炎 转换疗法 小儿 

分 类 号：R725.6[医药卫生—儿科]